News

Discovery Clinical Trials Announces Inclusion on Inc List for Third Year in a Row

Synergyst Research Group / Discovery Clinical Trials has been ranked on the Inc. 500|5000 list of the fastest-growing companies in the United States for the third year in a row, the magazine has announced.

Synergyst spin-off is on a fast-track path San Antonio Business Journal

Only two months after entering South Florida, Synergyst Research has signed deals to help manage clinical trials for two large physician practices. The agreements allow the medical practices to earn money from pharmaceutical and biotech companies as they test new drugs. Clinical trials typically pay two or three times the patient care rates for Medicare, which is scheduled to cut its physician payments by 15 percent over the next two years. Read more: Synergyst spin-off is on a fast-track path – San Antonio Business Journal:

Discovering hope for the future – Nside Medical

The basic concept of clinical research has not changed since it was first discovered. It begins with a concept, and it ends with a theory. New medicines are developed through a series of controlled trials, which assess the safety and efficacy of each new medicine by applying high scientific standards.

Testing a new drug on patients used to be done at universities, which could count on hundreds of millions of dollars a year to conduct the trials. But as pharmaceutical companies look to cut costs and get drugs to market quicker, outsourcing to other companies is an increasingly popular option. The change is gaining importance in North Texas, because the Dallas-Fort Worth area is becoming a hot spot for clinical trials. Read more: Dallas area sees significant growth in clinical trials – Dallas News.com: